STAT May 16, 2024
Lev Facher

SAN FRANCISCO — Amid what feels like an ever-worsening drug crisis here, locals and politicians alike are fed up. Overdose death rates remain near all-time highs. The Tenderloin, a historic downtown neighborhood, remains rife with open-air substance use and drug dealing. Public health officials are increasingly at a loss.

In recent years, much of the backlash has come to focus on harm reduction, the philosophy and practice of reducing the most acute drug-related harms without expecting abstinence from drug users.

But the solution is not a return to the “war on drugs,” a panel of addiction experts warned on Thursday, even as they acknowledged that the public has come to view hands-off drug policies, tolerance for open-air drug markets, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mental Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Behavioral health needs better metrics — Centerstone steps up
Wellpath's behavioral health unit becomes independent company
1 system's 'no wrong door' strategy for behavioral health
Prisma Health opens $3.7 million behavioral health facility
‘Not For the Faint of Heart’: What Makes (or Breaks) Mental Health Payer Pilots

Share This Article